James Wilbur compensation by year
10x Genomics Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $171,282 |
| Bonus | $219,500 |
| Stock awards | $3,226,899 |
| Option awards | $5,274,371 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $0 |
| Total | $8,892,052 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: 10x Genomics, Inc. DEF 14A filed April 28, 2023, accession 0001770787-23-000021, and prior-year filings. Open the filing on EDGAR.
How this page was built: the 10x Genomics, Inc. filed document, accession 0001770787-23-000021. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 95,839 | $3,492,373 | — |
| Option | 239,596 | — | $33.67 |
Per the Outstanding Equity Awards at Fiscal Year-End table in 10x Genomics, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
10x Genomics’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $18,805,294 |
| Eric Whitaker | Chief Legal Officer | $11,903,680 |
| Benjamin Hindson | President and Chief Scientific Officer | $9,869,889 |
| James Wilbur · this page | Chief Commercial Officer | $8,892,052 |
| Justin McAnear | Chief Financial Officer | $6,842,330 |
The full 10x Genomics compensation record
free company briefThis page is one person within 10x Genomics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the 10x Genomics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are 10x Genomics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.